Showing results (1091-1100 of 1,136) with videos related to

Sort By:
Pageof 114
Cell Reports|September 1, 2021
Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding proteinMichael P Doyle, Nurgun Kose, Viktoriya Borisevich, et al.
Topics in Spinal Cord Injury Rehabilitation|June 30, 2025
Exploring the Landscape of Biomarkers in Spinal Cord InjuryPaulina S Scheuren, Bethany R Kondiles, Angela R Filous, et al.
Plos Neglected Tropical Diseases|March 7, 2022
Pan-ebolavirus serology study of healthcare workers in the Mbandaka Health Region, Democratic Republic of the CongoKelly C L Shaffer, Sean Hui, Anna Bratcher, et al.
The Journal of Physiology|September 19, 2022
A cross-species validation of single-beat metrics of cardiac contractilityMehdi Ahmadian, Alexandra M Williams, Joseph Mannozzi, et al.
The Lancet. Respiratory Medicine|October 6, 2019
Effect of a fluid bolus on cardiovascular collapse among critically ill adults undergoing tracheal intubation (PrePARE): a randomised controlled trialDavid R Janz, Jonathan D Casey, Matthew W Semler, et al.
Neurosurgery|November 5, 2025
Multi-Institutional Assessment of Circulating Cell-Free DNA in Cerebrospinal Fluid Facilitates Central Nervous System Lymphoma Diagnosis and Treatment InitiationBriana C Prager, Mihir Gupta, Timothy R West, et al.
BMJ (Clinical Research Ed.)|February 18, 2022
Early identification of patients admitted to hospital for covid-19 at risk of clinical deterioration: model development and multisite external validation studyFahad Kamran, Shengpu Tang, Erkin Otles, et al.
Nature Structural & Molecular Biology|March 6, 2019
Structural basis of broad ebolavirus neutralization by a human survivor antibodyBrandyn R West, Anna Z Wec, Crystal L Moyer, et al.
Journal for Immunotherapy of Cancer|July 15, 2025
Engineered IL-18 variants with half-life extension and improved stability for cancer immunotherapyTravis W Bainbridge, Lifen Wang, Marina Moskalenko, et al.
Science Translational Medicine|April 3, 2024
Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primatesLarry Zeitlin, Robert W Cross, Courtney Woolsey, et al.
Pageof 114